Legal & General Group »

Outlook Therapeutics shares owned by Legal & General Group

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Legal & General Group from 13F filings

Historical chart of Legal & General Group investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Legal & General Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Legal & General Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.9k 829 11.94

More positions owned by Legal & General Group

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Visa Com Cl A (V)
Mastercard Incorporated Cl A (MA)
Johnson & Johnson (JNJ)

View all positions for Legal & General Group

Top funds holding Outlook Therapeutics

Tang Capital Management
Dr. Jeffrey R. Jay, M.D.
Armistice Capital
Sphera Funds Management
BlackRock
Velan Capital Investment Management
Caligan Partners
Vanguard Group
Schonfeld Strategic Advisors
Geode Capital Management
Northern Trust
Bank of America Corporation
Walleye Trading Advisors
Hrt Financial
Millennium Management

View all funds holding Outlook Therapeutics